Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Published 03/05/2024, 10:57
Updated 03/05/2024, 12:10
© Reuters Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
AAPL
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of Apple Inc. (NASDAQ:AAPL) rose sharply in today's pre-market trading after the company reported better reported better-than-expected results for its second quarter.

The company announced a $110-billion stock buyback program and a one-penny-per-share increase in its quarterly dividend.

Apple shares jumped 5.9% to $183.24 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Vaxxinity, Inc. (NASDAQ:VAXX) gained 45.8% to $0.1519 in pre-market trading after falling 9% on Thursday. Vaxxinity recently announced its intention to voluntarily delist and deregister its Class A common stock.
  • El Pollo Loco Holdings, Inc. (NASDAQ:LOCO) gained 23.1% to $10.59 in pre-market trading after the company reported better-than-expected first-quarter results.
  • AXT, Inc. (NASDAQ:AXTI) rose 23.8% to $3.75 in today's pre-market trading after the company reported better-than-expected first-quarter financial results.
  • Jaguar Health, Inc. (NASDAQ:JAGX) jumped 20.7% to $0.3540 in pre-market trading after surging 30% on Thursday.
  • Ardelyx, Inc. (NASDAQ:ARDX) shares gained 19.2% to $8.09 in pre-market trading after the company reported better-than-expected first-quarter financial results.
  • OneSpan Inc. (NASDAQ:OSPN) shares gained 18.6% to $13.00 in pre-market trading after the company reported better-than-expected first-quarter adjusted EPS and sales.
  • Rapid Micro Biosystems Inc (NASDAQ:RPID) shares rose 16.2% to $1.15 in pre-market trading.
  • The OLB Group, Inc. (NASDAQ:OLB) shares gained 19.8% to $0.5636 in pre-market trading after gaining 12% on Thursday. The company announced its shareholders approve a 1-for-10 reverse split.
  • Amgen Inc. (NASDAQ:AMGN) shares rose 14.2% to $318.01 in pre-market trading after the company reported better-than-expected first-quarter financial results. Also, the company announced a $50 million milestone payment from Royalty Pharma.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  • NanoVibronix, Inc. (NASDAQ:NAOV) fell 44.8% to $0.3988 in pre-market trading after gaining 7% on Thursday.
  • Sprout Social, Inc. (NASDAQ:SPT) shares declined 25.2% to $36.00 in pre-market trading after the company reported worse-than-expected first-quarter revenue results.
  • Marin Software Incorporated (NASDAQ:MRIN) fell 19.4% to $2.54 in pre-market trading after the company reported a year-over-year decrease on first-quarter revenue results.
  • Stem, Inc. (NYSE:STEM) shares fell 18.7% to $1.55 in pre-market trading after the company reported worse-than-expected first-quarter financial results and cut its FY24 revenue guidance.
  • Terran Orbital Corporation (NYSE:LLAP) shares fell 18.5% to $1.05 in pre-market trading fter Lockheed Martin withdrew its buyout proposal.
  • Cloudflare, Inc. (NYSE:NET) fell 14% to $76.50 pre-market trading after the company reported first-quarter financial results and issued FY24 revenue guidance below estimates.
  • Trupanion, Inc. (NASDAQ:TRUP) shares declined 13% to $20.68 in pre-market trading following first-quarter results.
  • BigBear.ai Holdings, Inc. (NYSE:BBAI) shares fell 12.1% to $1.52 in pre-market trading after the company reported worse-than-expected first-quarter financial results.
  • Expedia Group, Inc. (NASDAQ:EXPE) shares declined 10.1% to $121.92 in pre-market trading after the company lowered its full-year guidance.
  • Fortinet, Inc. (NASDAQ:FTNT) fell 8.3% to $59.81 pre-market trading after the company reported its first-quarter financial results.

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.